Literature DB >> 28760889

Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity.

Marie Roelens1,2,3, Marc Delord2,4, Caroline Ram-Wolff2,5,6, Anne Marie-Cardine2,5, Antonio Alberdi2,7, Guitta Maki3, Laurence Homyrda3, Armand Bensussan2,5, Martine Bagot2,5,6, Antoine Toubert1,2,3, Hélène Moins-Teisserenc1,2,3.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28760889     DOI： 10.1182/blood-2017-03-772996

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Single-cell heterogeneity in Sézary syndrome.

Authors:  Terkild Brink Buus; Andreas Willerslev-Olsen; Simon Fredholm; Edda Blümel; Claudia Nastasi; Maria Gluud; Tengpeng Hu; Lise M Lindahl; Lars Iversen; Hanne Fogh; Robert Gniadecki; Ivan V Litvinov; Jenny L Persson; Charlotte Menné Bonefeld; Carsten Geisler; Jan Pravsgaard Christensen; Thorbjørn Krejsgaard; Thomas Litman; Anders Woetmann; Niels Ødum
Journal:  Blood Adv       Date:  2018-08-28

2.  Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.

Authors:  Pedro Horna; Lynn C Moscinski; Lubomir Sokol; Haipeng Shao
Journal:  Cytometry B Clin Cytom       Date:  2018-10-16       Impact factor: 3.058

Review 3.  Cutaneous T cell lymphoma.

Authors:  Reinhard Dummer; Maarten H Vermeer; Julia J Scarisbrick; Youn H Kim; Connor Stonesifer; Cornelis P Tensen; Larisa J Geskin; Pietro Quaglino; Egle Ramelyte
Journal:  Nat Rev Dis Primers       Date:  2021-08-26       Impact factor: 52.329

Review 4.  Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome.

Authors:  Cristina Cristofoletti; Antonella Bresin; Martina Fioretti; Giandomenico Russo; Maria Grazia Narducci
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

Review 5.  CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies.

Authors:  Van To; Vera J Evtimov; Graham Jenkin; Aleta Pupovac; Alan O Trounson; Richard L Boyd
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

Review 6.  Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach.

Authors:  Maarten H Vermeer; Helene Moins-Teisserenc; Martine Bagot; Pietro Quaglino; Sean Whittaker
Journal:  Br J Dermatol       Date:  2022-05-03       Impact factor: 11.113

7.  Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity.

Authors:  Martina Prochazkova-Carlotti; Floriane Cherrier; Audrey Gros; Sandrine Poglio; Elodie Laharanne; Anne Pham-Ledard; Marie Beylot-Barry; Jean-Philippe Merlio
Journal:  Leukemia       Date:  2020-10-26       Impact factor: 11.528

Review 8.  Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.

Authors:  Melissa P Pulitzer; Pedro Horna; Julia Almeida
Journal:  Cytometry B Clin Cytom       Date:  2020-06-09       Impact factor: 3.248

Review 9.  Gene Expression Comparison between Sézary Syndrome and Lymphocytic-Variant Hypereosinophilic Syndrome Refines Biomarkers for Sézary Syndrome.

Authors:  Andrea Moerman-Herzog; Syed J Mehdi; Henry K Wong
Journal:  Cells       Date:  2020-08-29       Impact factor: 6.600

10.  CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome.

Authors:  Inès Vergnolle; Claudia Douat-Beyries; Serge Boulinguez; Jean-Baptiste Rieu; Jean-Philippe Vial; Rolande Baracou; Sylvie Boudot; Aurore Cazeneuve; Sophie Chaugne; Martine Durand; Sylvie Estival; Nicolas Lablanche; Marie-Laure Nicolau-Travers; Emilie Tournier; Laurence Lamant; François Vergez
Journal:  Blood Adv       Date:  2022-03-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.